Summary
-
1.
The proposal that calcium antagonists have different sites of action has been tested by attempting to reverse their inhibitory effects with a dihydropyridine which augments Ca2+ entry into cells, Bay K 8644.
-
2.
Bay K 8644 (1–1000 nmol/l) increased the sensitivity to Ca2+ of K+-depolarized taenia preparations from the guinea-pig caecum. Thus Bay K 8644 augmented established submaximal Ca2+-induced contractions and also shifted cumulative concentration-response curves to Ca2+ to the left, even in the presence of an optimal K+-depolarization.
-
3.
The inhibitory effects of nifedipine (10 nmol/l), verapamil (0.2 μmol/l), diltiazem (1 μmol/l) and diclofurime (1 μmol/l) on Ca2+-induced contractions were reversed by Bay K 8644 (1–100 nmol/l). In contrast, Bay K 8644 did not reverse the effects of cinnarizine (1 μmol/l), flunzrizine (1 μmol/l), fendiline (3 μmol/l), prenylamine (3 μmol/l), pimozide (1 μmol/l), bepridil (3 μmol/l), perhexiline (10 μmol/l) or the calmodulin antagonist W-7 (200 μmol/l).
-
4.
Bay K 8644 (1–100 nmol/l) was less effective at reversing the effects of nisoldipine (10 nmol/l), a slowly dissociating dihydropyridine, than the effects of nifedipine. However, preincubation with Bay K 8644 (1 μmol/l) protected the taenia from the inhibitory effects of nisoldipine (10 nmol/l). These findings are compatible with interactions of nisoldipine and Bay K 8644 at a common site.
-
5.
Taenia preparations incubated with Bay K 8644 (1 μmol/l) were protected from the inhibitory effects of nifedipine (10 nmol/l), nisoldipine (10 nmol/l) and to a lesser extent verapamil (0.2 μmol/l) and diltiazem (1 μmol/l). However, there was no protection against the inhibitory effects of cinnarizine (1 μmol/l), flunarizine (1 μmol/l), pimozide (1 μmol/l), fendiline (3 μmol/l), prenylamine (3 μmol/l) or W-7 (200 μmol/l). Thus, the lack of protection indicates that there is no interaction between the dihydropyridine site and the site for the latter drugs. These experiments show that Bay K 8644 defines subgroups of calcium antagonists which are the same as those previously reported from functional studies.
Similar content being viewed by others
References
Albus U, Habermann E, Ferry DR, Glossmann H (1984) Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent (3H)noradrenaline release from PC12 cells. J Neurochem 42:1186–1189
Anno T, Furuta T, Itoh M, Kodama I, Toyama J, Yamada K (1984) Electromechanical effects of bepridil on rabbit isolated hearts. Br J Pharmacol 81:41–47
Arunlakshana O, Schild HO (1959) Some quantitative used of drug antagonists. Br J Pharmacol Chemother 14:48–58
Bayer R, Kaufmann R, Mannhold R, Rodenkirchen R (1982) The action of specific Ca antagonists on cardiac electrical activity. Progr Pharmacol 5:53–85
Bellemann P, Schade A, Towart R (1983) Dihydropyridine receptor in rat brain labelled with (3H)nimodipine. Proc Natl Acad Sci USA 80:2356–2360
Bolger GT, Gengo P, Klockowski E, Luchowski E, Siegel H, Janis RA, Triggle AM, Triggle DJ (1983) Characterization of binding of the Ca2+ channel antagonist, (3H)nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther 225:291–309
Bou J, Llenas J, Massingham R (1983) Calcium entry blocking drugs, “calcium antagonists” and vascular smooth muscle function. J Auton Pharmacol 3:219–232
DePover A, Matlib MA, Lee SW, Dubé GP, Grupp IL, Grupp G, Schwartz A (1982) Specific binding of (3H)nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Comm 108:110–117
Ehlert FJ, Itoga E, Roeske WR, Yamamura HI (1982) The interaction of (3H)nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. Biochem Biophys Res Comm 104:937–943
Ferry DR, Glossmann H (1982) Evidence for multiple receptor sites within the putative calcium channel. Naunyn-Schmiedeberg's Arch Pharmacol 321:80–83
Fleckenstein A (1981) Fundamental actions of calcium antagonists on myocardial and cardiac pacemaker cell membranes. In: Weiss GB (ed) New perspectives on calcium antagonists. Am Physiol Soc Baltimore, pp 59–81
Gittos M, Spedding M (1984) Comparison of cis and trans diclofurime with verapamil as calcium antagonists. Br J Pharmacol 81:81P
Glossmann H, Ferry DR, Lübbecke F, Mewes R, Hofmann F (1982) Calcium channels: direct identification with radioligand binding studies. Trends Pharmacol Sci 3:431–437
Glossmann H, Linn T, Rombusch M, Ferry DR (1983) Temperature-dependent regulation of d-cis-(3H)diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. FEBS Lett 160:226–232
Godfraind T, Hardy JP, Morel N (1984) The action of the spasmogenic dihydropyridine Bay K 8644 on the mechanical and the electrical activity of guinea-pig taenia coli. Arch int Pharmacodyn Ther 268:167–168
Gould RJ, Murphy KMM, Reynolds IJ, Snyder SH (1983) Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc Natl Acad Sci USA 80:5122–5125
Hof RP (1984) Selective effects of different calcium antagonists on the peripheral circulation. Trends Pharmacol Sci 5:100–103
Humphrey PPA, Robertson MJ (1983) Functional characteristics of verapamil and nitrendipine interactions at calcium channels in smooth muscle. Br J Pharmacol 80:502P
Inomata H, Kao CY (1976) Ionic currents in the guine-pig taenia coli. J Physiol 255:347–378
Johnson JD, Fugman DA (1983) Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments. J Pharmacol Exp Ther 226:330–334
Karaki H, Murakami K, Nakagawa H, Ozaki H, Urakawa N (1982) Effects of calmodulin antagonists on tension and cellular calcium content in depolarized vascular and intestinal smooth muscles. Br J Pharmacol 77:661–666
Kazda S, Towart R (1982) The duration of action of calcium antagonists in vitro: a comparison of nifedipine and nisoldipine (Bay K 5552). Br J Pharmacol 76:255P
Kazda S, Knorr A, Towart R (1983) Common properties and differences between various calcium antagonists. Progr Pharmacol 5:84–116
Landry Y, Amellal M, Ruckstuhl M (1981) Can calmodulin inhibitors be used to probe calmodulin effects? Biochem Pharmacol 30:2031–2032
Levin RM, Weiss GB (1979) Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activation of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther 208:454–459
Lugnier C, Follenius A, Gerard D, Stoclet JC (1984) Bepridil and flunarizine as calmodulin inhibitors. Eur J Pharmacol 98: 157–158
Marangos PJ, Patel J, Miller C, Martino AM (1982) Specific calcium antagonist binding sites in brain. Life Sci 31: 1575–1585
Murphy KMM, Gould RJ, Largent BL, Snyder SH (1983) A unitary mechanism of calcium antagonist drug action. Proc Natl Acad Sci USA 80:860–864
Opie LH (1980) Calcium antagonists. Lancet 1:806–810
Reynolds IJ, Gould RJ, Snyder SH (1983) (3H)Verapamil binding sites in brain and skeletal muscle: regulation by calcium. Eur J Pharmacol 95:315–321
Riemer J, Dörfler F, Mayer C-J, Ulbrecht G (1974) Calcium antagonistic effects on the spontaneous activity of guinea-pig taenia coli. Pflüger's Arch ges Physiol 351:33–37
Rodenkirchen R, Bayer R, Mannhold R (1982) Specific and non-specific Ca antagonists. A structure-activity analysis of cardiodepressive drugs. Progr Pharmacol 5:9–23
Sarmiento JG, Janis RA, Maurer SC, Katz AM, Triggle DJ, Luchowski E (1983) Comparison of high affinity binding sites for Ca2+ channel inhibitors in membranes for various tissues. Is calmodulin at the binding site for Ca2+ channel inhibitors? Pharmacologist 25:202
Sarmiento JG, Janis RA, Rampe D, Triggle DJ (1984) (3H) Bay K 8644, a calcium channel agonist, binds to high and low affinity sites on membranes from cardiac muscle and brain. Fed Proc 43:448
Schramm M, Thomas G, Towart R, Franckowiak G (1983a) Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 309:535–537
Schramm M, Thomas G, Towart R, Franckowiak G (1983b) Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants. Arzneim-Forsch 33:1268–1272
Schramm M, Towart R (1984) Modulation of calcium channel function with 1,4-dihydropyridine structure. J Physiol 349: 53P
Sparrow MP, Mrwa U, Hofmann F, Rüegg JC (1981) Calmodulin is essential for smooth muscle contractions. FEBS Lett 125: 141–145
Spedding M (1981) Marked differences in the effects of “Ca2+ antagonists” on CaCl2-induced contractions in K+-depolarized smooth muscle. Br J Pharmacol 72:144P
Spedding M (1982a) Assessment of “Ca2+-antagonist” effects of drugs in K+-depolarized smooth muscle. Differentiation of antagonist subgroups. Naunyn-Schmiedeberg's Arch Pharmacol 318: 234–240
Spedding M (1982b) Differences between the effects of calcium antagonists in the pithed rat preparation. J Cardiovasc Pharmacol 4:973–979
Spedding M (1983a) Direct inhibitory effects of some “calcium antagonists” and trifluoperazine on the contractile proteins in smooth muscle. Br J Pharmacol 79:225–231
Spedding M (1983b) The effects of changing surface charge with salicylate on the potency of calcium antagonists in smooth muscle. Br J Pharmacol 78:36P
Spedding M (1983c) Functional interactions of calcium antagonists in K+-depolarized smooth muscle. Br J Pharmacol 80: 485–488
Spedding M (1984a) Changing surface charge with salicylate differentiates between subgroups of calcium antagonists. Br J Pharmacol, in press
Spedding M (1984b) Calcium antagonist subgroups. Trends Pharmacol Sci: in press
Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol Chemother 11:379–393
Towart R, Schramm M (1984) Recent advances in the pharmacology of the calcium channel. Trends Pharmacol Sci 5:111–113
Triggle DJ (1984) Ca2+ channels revisited: problems and promises. Trends Pharmacol Sci 5:4–5
Van Rossum JM (1963) Cumulative dose-response curves II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn 143:299–330
Wadsworth RM, Moss JP (1983) Time course of the effect of flunarizine on rabbit isolated vascular muscle. Eur J Pharmacol 85:207–209
Williams LT, Tremble P (1982) Binding of a calcium antagonist, (3H)nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. J Clin Inv 70:209–212
Yamamura HI, Schoemaker H, Boles RG, Roeske WR (1982) Diltiazem enhancement of (3H)nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. Biochem Biophys Res Comm 108:640–646
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spedding, M., Berg, C. Interactions between a “calcium channel agonist”, Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 69–75 (1984). https://doi.org/10.1007/BF00496109
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00496109